| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Elephants | 22 | 2025 | 45 | 10.870 |
Why?
|
| Herpesviridae Infections | 24 | 2025 | 147 | 10.520 |
Why?
|
| Herpesviridae | 19 | 2025 | 35 | 8.870 |
Why?
|
| Viral Proteins | 18 | 2020 | 360 | 2.970 |
Why?
|
| Herpesvirus 4, Human | 26 | 2019 | 675 | 2.900 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 22 | 2019 | 60 | 2.680 |
Why?
|
| Animals, Zoo | 8 | 2025 | 17 | 1.710 |
Why?
|
| Epstein-Barr Virus Infections | 8 | 2015 | 293 | 1.380 |
Why?
|
| Cell Transformation, Viral | 7 | 2019 | 99 | 1.210 |
Why?
|
| B-Lymphocytes | 12 | 2019 | 551 | 1.170 |
Why?
|
| Viremia | 6 | 2022 | 136 | 1.160 |
Why?
|
| DNA, Viral | 11 | 2016 | 500 | 1.150 |
Why?
|
| Nuclear Proteins | 10 | 2013 | 1351 | 1.150 |
Why?
|
| Vaccines, Subunit | 2 | 2024 | 70 | 1.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2016 | 548 | 1.030 |
Why?
|
| Immunity, Cellular | 2 | 2024 | 218 | 1.010 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 510 | 1.010 |
Why?
|
| Transcriptional Activation | 10 | 2015 | 504 | 0.980 |
Why?
|
| Gene Expression Regulation, Viral | 10 | 2019 | 136 | 0.940 |
Why?
|
| Viral Matrix Proteins | 7 | 2011 | 110 | 0.940 |
Why?
|
| Viral Tropism | 1 | 2025 | 53 | 0.930 |
Why?
|
| Immunity, Humoral | 1 | 2024 | 76 | 0.860 |
Why?
|
| Rhadinovirus | 2 | 2013 | 4 | 0.850 |
Why?
|
| Animals | 34 | 2025 | 36557 | 0.830 |
Why?
|
| Vaccinia | 1 | 2022 | 8 | 0.770 |
Why?
|
| Herpesvirus 3, Equid | 1 | 2021 | 4 | 0.750 |
Why?
|
| Hemorrhagic Disorders | 1 | 2021 | 22 | 0.740 |
Why?
|
| Transcription Factors | 5 | 2013 | 2738 | 0.700 |
Why?
|
| Animal Diseases | 1 | 2020 | 7 | 0.660 |
Why?
|
| Cell Nucleus | 6 | 2009 | 691 | 0.660 |
Why?
|
| Virus Latency | 7 | 2019 | 64 | 0.640 |
Why?
|
| Betaherpesvirinae | 2 | 2020 | 5 | 0.640 |
Why?
|
| Molecular Sequence Data | 20 | 2015 | 3980 | 0.630 |
Why?
|
| Antigens, Nuclear | 3 | 2011 | 57 | 0.620 |
Why?
|
| Antibodies, Viral | 6 | 2024 | 1211 | 0.620 |
Why?
|
| Autoantigens | 3 | 2011 | 118 | 0.610 |
Why?
|
| Viral Load | 3 | 2013 | 412 | 0.570 |
Why?
|
| Antigens, Viral | 7 | 2020 | 441 | 0.550 |
Why?
|
| Trans-Activators | 3 | 2015 | 840 | 0.530 |
Why?
|
| Base Sequence | 15 | 2016 | 3180 | 0.500 |
Why?
|
| Virus Replication | 4 | 2013 | 637 | 0.480 |
Why?
|
| Endangered Species | 1 | 2015 | 18 | 0.470 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 43 | 0.460 |
Why?
|
| Mutant Proteins | 1 | 2015 | 120 | 0.460 |
Why?
|
| Promoter Regions, Genetic | 10 | 2005 | 1433 | 0.460 |
Why?
|
| Rodent Diseases | 1 | 2013 | 17 | 0.440 |
Why?
|
| Ribonucleotide Reductases | 1 | 2013 | 11 | 0.430 |
Why?
|
| Host-Pathogen Interactions | 2 | 2013 | 266 | 0.420 |
Why?
|
| Peritoneum | 1 | 2013 | 40 | 0.420 |
Why?
|
| Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2013 | 3 | 0.410 |
Why?
|
| Varicellovirus | 1 | 2013 | 1 | 0.410 |
Why?
|
| Mouth Diseases | 1 | 2013 | 15 | 0.410 |
Why?
|
| Gammaherpesvirinae | 2 | 2013 | 6 | 0.400 |
Why?
|
| Cell Line | 10 | 2013 | 2864 | 0.400 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2013 | 35 | 0.400 |
Why?
|
| Sumoylation | 1 | 2013 | 40 | 0.400 |
Why?
|
| DNA-Binding Proteins | 11 | 2004 | 2178 | 0.400 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 85 | 0.400 |
Why?
|
| Veterinary Medicine | 1 | 2012 | 8 | 0.400 |
Why?
|
| Herpesvirus Vaccines | 2 | 2024 | 3 | 0.400 |
Why?
|
| 2-Aminopurine | 3 | 2017 | 4 | 0.390 |
Why?
|
| Virology | 1 | 2012 | 36 | 0.390 |
Why?
|
| Amino Acid Sequence | 12 | 2015 | 2795 | 0.370 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 62 | 0.360 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 68 | 0.360 |
Why?
|
| In Situ Hybridization | 3 | 2025 | 485 | 0.360 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 467 | 0.360 |
Why?
|
| Lymphoma, T-Cell | 1 | 2011 | 63 | 0.360 |
Why?
|
| Fibroblasts | 2 | 2013 | 928 | 0.360 |
Why?
|
| Genotype | 3 | 2013 | 2814 | 0.350 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 384 | 0.340 |
Why?
|
| Serologic Tests | 2 | 2021 | 131 | 0.340 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 393 | 0.330 |
Why?
|
| Transcription, Genetic | 5 | 2005 | 1761 | 0.330 |
Why?
|
| Promyelocytic Leukemia Protein | 3 | 2013 | 13 | 0.320 |
Why?
|
| Mice | 8 | 2024 | 19055 | 0.320 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 357 | 0.310 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1812 | 0.310 |
Why?
|
| Virus Shedding | 2 | 2013 | 82 | 0.300 |
Why?
|
| Cytoplasm | 1 | 2009 | 304 | 0.290 |
Why?
|
| Interferons | 1 | 2008 | 145 | 0.280 |
Why?
|
| Polymerase Chain Reaction | 5 | 2023 | 1627 | 0.270 |
Why?
|
| Cytomegalovirus | 2 | 2011 | 271 | 0.270 |
Why?
|
| RNA, Messenger | 7 | 2015 | 2915 | 0.270 |
Why?
|
| Blotting, Western | 3 | 2015 | 1140 | 0.270 |
Why?
|
| Male | 15 | 2025 | 66127 | 0.260 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 787 | 0.260 |
Why?
|
| Antiviral Agents | 3 | 2017 | 824 | 0.260 |
Why?
|
| MicroRNAs | 2 | 2019 | 951 | 0.250 |
Why?
|
| DNA Primers | 4 | 2015 | 672 | 0.240 |
Why?
|
| Female | 15 | 2025 | 71928 | 0.240 |
Why?
|
| Viral Envelope Proteins | 2 | 2024 | 156 | 0.240 |
Why?
|
| Herpesvirus 1, Equid | 1 | 2024 | 2 | 0.230 |
Why?
|
| North America | 1 | 2025 | 263 | 0.230 |
Why?
|
| Saliva | 3 | 2017 | 133 | 0.220 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2003 | 272 | 0.220 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 294 | 0.210 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2015 | 673 | 0.210 |
Why?
|
| JC Virus | 1 | 2003 | 29 | 0.210 |
Why?
|
| Lymphocytes | 1 | 2005 | 442 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 867 | 0.200 |
Why?
|
| Sequence Alignment | 5 | 2010 | 633 | 0.200 |
Why?
|
| Molecular Epidemiology | 1 | 2003 | 162 | 0.200 |
Why?
|
| BK Virus | 1 | 2003 | 61 | 0.200 |
Why?
|
| Virus Activation | 1 | 2003 | 85 | 0.200 |
Why?
|
| Proteolysis | 2 | 2013 | 199 | 0.190 |
Why?
|
| HIV-1 | 2 | 2003 | 488 | 0.190 |
Why?
|
| Immunoglobulin G | 2 | 2015 | 825 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 1 | 2024 | 1089 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1332 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 1837 | 0.180 |
Why?
|
| Immunity | 1 | 2022 | 187 | 0.180 |
Why?
|
| HeLa Cells | 3 | 2015 | 838 | 0.180 |
Why?
|
| Genome, Viral | 2 | 2013 | 185 | 0.180 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 2172 | 0.180 |
Why?
|
| HIV Infections | 3 | 2004 | 2075 | 0.170 |
Why?
|
| Immunoprecipitation | 2 | 2015 | 206 | 0.170 |
Why?
|
| Peptides | 2 | 2002 | 863 | 0.170 |
Why?
|
| Glycoproteins | 1 | 2022 | 381 | 0.160 |
Why?
|
| Protein Interaction Mapping | 2 | 2013 | 94 | 0.160 |
Why?
|
| Specimen Handling | 1 | 2020 | 148 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 2010 | 295 | 0.150 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 497 | 0.150 |
Why?
|
| Open Reading Frames | 2 | 2010 | 220 | 0.150 |
Why?
|
| Carrier Proteins | 1 | 2004 | 1077 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2019 | 2563 | 0.150 |
Why?
|
| Cloning, Molecular | 5 | 2015 | 912 | 0.140 |
Why?
|
| Humans | 25 | 2019 | 134156 | 0.140 |
Why?
|
| Asia | 1 | 2018 | 127 | 0.140 |
Why?
|
| Protein Transport | 2 | 2009 | 390 | 0.140 |
Why?
|
| RNA, Viral | 3 | 2011 | 563 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 434 | 0.140 |
Why?
|
| Papio | 4 | 2000 | 60 | 0.130 |
Why?
|
| Binding Sites | 6 | 2004 | 1384 | 0.130 |
Why?
|
| Receptors, IgE | 2 | 1994 | 11 | 0.120 |
Why?
|
| Lymphocryptovirus | 3 | 2000 | 3 | 0.120 |
Why?
|
| Protein Binding | 3 | 2009 | 1859 | 0.120 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 49 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2019 | 3188 | 0.120 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 97 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 258 | 0.120 |
Why?
|
| Sequence Deletion | 2 | 2008 | 539 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 311 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2015 | 152 | 0.110 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1994 | 66 | 0.110 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 225 | 0.110 |
Why?
|
| Immunoglobulin A | 1 | 2015 | 219 | 0.110 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 394 | 0.110 |
Why?
|
| Animals, Wild | 1 | 2014 | 30 | 0.110 |
Why?
|
| Fungal Proteins | 1 | 1994 | 143 | 0.110 |
Why?
|
| Acute-Phase Proteins | 1 | 2013 | 50 | 0.100 |
Why?
|
| Gene Expression | 2 | 2011 | 1621 | 0.100 |
Why?
|
| Rabies Vaccines | 1 | 2013 | 11 | 0.100 |
Why?
|
| India | 1 | 2014 | 239 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2001 | 1622 | 0.100 |
Why?
|
| Protein Conformation | 1 | 2015 | 873 | 0.100 |
Why?
|
| Tetanus Toxoid | 1 | 2013 | 50 | 0.100 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1999 | 322 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2003 | 239 | 0.100 |
Why?
|
| Genes, Viral | 2 | 2010 | 186 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 294 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 288 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 2669 | 0.090 |
Why?
|
| Immunization | 1 | 2013 | 315 | 0.090 |
Why?
|
| Immediate-Early Proteins | 1 | 2011 | 60 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2013 | 837 | 0.090 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 407 | 0.090 |
Why?
|
| Transfection | 2 | 2004 | 1096 | 0.080 |
Why?
|
| Phylogeny | 1 | 2013 | 785 | 0.080 |
Why?
|
| Pregnancy | 2 | 2013 | 7570 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2002 | 724 | 0.080 |
Why?
|
| Gene Amplification | 1 | 2010 | 247 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1044 | 0.080 |
Why?
|
| Estrogens | 2 | 2002 | 525 | 0.080 |
Why?
|
| Plasmids | 1 | 2010 | 529 | 0.080 |
Why?
|
| DNA | 2 | 2000 | 1682 | 0.080 |
Why?
|
| Reference Values | 1 | 2010 | 741 | 0.080 |
Why?
|
| Carcinoma | 1 | 2011 | 322 | 0.080 |
Why?
|
| Structure-Activity Relationship | 3 | 1995 | 611 | 0.070 |
Why?
|
| Conserved Sequence | 3 | 2000 | 300 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 125 | 0.070 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 3 | 2004 | 14 | 0.070 |
Why?
|
| Time Factors | 2 | 2013 | 6610 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 97 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1071 | 0.070 |
Why?
|
| Texas | 1 | 2016 | 3716 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 3043 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 278 | 0.070 |
Why?
|
| Adult | 5 | 2015 | 31945 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2010 | 408 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2009 | 874 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2000 | 319 | 0.060 |
Why?
|
| Mutation | 2 | 2015 | 6338 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 169 | 0.060 |
Why?
|
| Receptors, Complement 3d | 1 | 2005 | 8 | 0.060 |
Why?
|
| Transcription Factor HES-1 | 1 | 2005 | 20 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 69 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 645 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2013 | 4016 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1440 | 0.060 |
Why?
|
| Leukoplakia, Hairy | 1 | 2004 | 1 | 0.060 |
Why?
|
| Acyclovir | 1 | 2004 | 47 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1923 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 54 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1995 | 328 | 0.050 |
Why?
|
| LIM Domain Proteins | 1 | 2004 | 64 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2005 | 207 | 0.050 |
Why?
|
| Genes, myc | 1 | 2004 | 107 | 0.050 |
Why?
|
| Valine | 1 | 2004 | 116 | 0.050 |
Why?
|
| Alleles | 1 | 2008 | 1724 | 0.050 |
Why?
|
| Urine | 1 | 2003 | 92 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 1721 | 0.050 |
Why?
|
| In Vitro Techniques | 2 | 1995 | 993 | 0.050 |
Why?
|
| Burkitt Lymphoma | 1 | 2004 | 141 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 284 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 915 | 0.050 |
Why?
|
| Genetic Complementation Test | 1 | 2002 | 90 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 406 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2023 | 94 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2002 | 58 | 0.050 |
Why?
|
| HIV Antibodies | 1 | 2002 | 71 | 0.050 |
Why?
|
| Culture Media | 1 | 2002 | 184 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 589 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 358 | 0.050 |
Why?
|
| Seasons | 1 | 2003 | 334 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2002 | 130 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 596 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2001 | 80 | 0.040 |
Why?
|
| Nuclear Localization Signals | 1 | 2000 | 16 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 276 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2000 | 5 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 214 | 0.040 |
Why?
|
| Food Microbiology | 1 | 2020 | 25 | 0.040 |
Why?
|
| Ireland | 1 | 2020 | 34 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 628 | 0.040 |
Why?
|
| Animal Feed | 1 | 2020 | 83 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2020 | 49 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 172 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2000 | 263 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 774 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2002 | 811 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2005 | 556 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2002 | 521 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 1107 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 1506 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1998 | 388 | 0.030 |
Why?
|
| Apoptosis | 1 | 2004 | 1946 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 789 | 0.030 |
Why?
|
| Age Factors | 1 | 2003 | 2998 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3798 | 0.030 |
Why?
|
| Prevalence | 1 | 2003 | 2684 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 710 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2000 | 622 | 0.030 |
Why?
|
| Azacitidine | 1 | 1995 | 53 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1995 | 194 | 0.030 |
Why?
|
| Solubility | 1 | 1995 | 145 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1994 | 59 | 0.030 |
Why?
|
| Europe | 1 | 2015 | 382 | 0.030 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1993 | 3 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1995 | 160 | 0.030 |
Why?
|
| Macaca mulatta | 3 | 2000 | 513 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1993 | 40 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1993 | 41 | 0.030 |
Why?
|
| Vero Cells | 1 | 1993 | 113 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1994 | 189 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 609 | 0.020 |
Why?
|
| Biological Transport | 1 | 1993 | 371 | 0.020 |
Why?
|
| Middle Aged | 2 | 2003 | 29399 | 0.020 |
Why?
|
| Proteins | 1 | 1998 | 1101 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 247 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1993 | 1126 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2000 | 4934 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2004 | 33 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 20624 | 0.010 |
Why?
|
| Epithelium | 1 | 2004 | 366 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 276 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 23 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 44 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 86 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 703 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 396 | 0.010 |
Why?
|
| Carrier State | 1 | 2002 | 78 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2002 | 178 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2000 | 49 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1304 | 0.010 |
Why?
|
| Monkey Diseases | 1 | 1999 | 18 | 0.010 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 1999 | 76 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 472 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2002 | 449 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 1999 | 141 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 1999 | 149 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1999 | 897 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1995 | 14 | 0.010 |
Why?
|
| Methylation | 1 | 1995 | 232 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 171 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 13240 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2004 | 17540 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2002 | 14884 | 0.000 |
Why?
|
| Child | 1 | 2002 | 25890 | 0.000 |
Why?
|